Placing Programme

RNS Number : 4982E

Axiom European Financial Debt Fd Ld

08 May 2017

 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S PERSONS OR IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

This announcement is an advertisement and not a prospectus. Any investment in any shares referred to in this announcement may be made only on the basis of information in the prospectus (the "Prospectus") published today by Axiom European Financial Debt Fund Limited.

8 May 2017

Axiom European Financial Debt Fund Limited

Placing Programme

Axiom European Financial Debt Fund Limited ("Axiom" or the "Company") today announces that it has published a prospectus approved by the UK Listing Authority relating to the creation of a placing programme (the "Placing Programme") pursuant to which the Company will be able to issue up to 500 million new ordinary shares of no par value ("Shares").

The Placing Programme will enable the Company to raise capital in an efficient and cost-effective manner over the next 12 months. The Placing Programme Price will include at the time of allotment a premium to the Net Asset Value per Share intended, inter alia, to cover the costs and expenses of the relevant placing of Shares (including, without limitation, any placing commissions).

The Prospectus will shortly be available on the national storage mechanism at www.morningstar.co.uk/uk/NSM and will also be available on the Company's website at http://www.axiom-ai.com/.

Capitalised terms used in this announcement shall have the same meanings as defined in the Prospectus unless otherwise defined herein.

Highlights:

·      The Placing Programme is intended to enable the Company to raise additional capital through the issue of up to 500 million Shares in the period from 8 May 2017 to 7 May 2018 (or, if sooner, the date on which the Placing Programme is fully utilised).

·      Funds raised from the Placing Programme will be used for investment in Financial Institution Investment Instruments in accordance with the Company's investment policy and are expected (but without restricting the Company) in particular to be deployed in the liquid relative value and less liquid relative value strategies.

·      Liberum Capital Limited ("Liberum") has been appointed as Sole Financial Adviser and Bookrunner in relation to the Placing Programme.

·      All Shares issued pursuant to the Placing Programme will, when issued and fully paid, confer the right to receive all dividends or other distributions made, paid or declared, if any, by reference to a record date after the date of their issue.

The information communicated in this announcement is inside information for the purposes of Article 7 of Market Abuse Regulation 596/2014 ("MAR"). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Steve Mann of Elysium Fund Management Limited.

For further information please contact:

Axiom Alternative Investments SARL David Benamou, Managing Partner Jerome Legras, Managing Partner Tel: + 44 (0)20 3807 0670
Liberum Capital Limited (Sole Financial Adviser and Bookrunner) Richard Bootle / Henry Freeman / Jonathan Wilkes-Green Tel:  [phone]

PLACING PROGRAMME STATISTICS

Maximum number of Shares under the Placing Programme	500 million Shares
Placing Programme Price	Not less than the prevailing Net Asset Value (cum income) per Share at the time of issue plus a premium to cover the costs and expenses of the relevant placing of Shares (including, without limitation, any placing commissions).
ISIN for Ordinary Shares	GG00BTC2K735
SEDOL for Ordinary Shares	BTC2K73
EPIC/TIDM	AXI

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa.  The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the US Investment Company Act of 1940, as amended and may not be offered or sold directly or indirectly in or into the United States or to or for the account or benefit of any U.S. Person (within the meaning of Regulation S under the Securities Act). The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa.

This announcement has been issued by and is the sole responsibility of the Company.

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by, Liberum Capital Limited ("Liberum") or by any of its affiliates or agents as to or in relation to the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers and any liability therefore is expressly disclaimed.

Liberum, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser to the Company and is acting for no-one else in connection with the Placing Programme and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Liberum or for providing advice in connection with the Placing Programme and the contents of this announcement or any other matter referred to herein.

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. All forward-looking statements address matters that involve risks and uncertainties. Accordingly, there are or will be important factors that could cause the Company's actual results to differ materially from those indicated in these statements. Any forward-looking statements in this announcement reflect the Directors' current views with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations and growth strategy. Prospective investors should specifically consider the factors identified in this announcement and the Prospectus which could cause actual results to differ before making an investment decision. These forward looking statements speak only as of the date of this announcement. Subject to its legal and regulatory requirements, the Company expressly disclaims any obligation to update or revise any forward-looking statement contained herein to reflect changes in expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based, unless required to do so by law or any appropriate regulatory authority, including FSMA, the London Stock Exchange, the GFSC, the RCIS Rules, the Prospectus Rules, MAR and the Disclosure Guidance and Transparency Rules.

This announcement does not constitute an invitation to engage investment activity.

The value of investments may go down as well as up, and all of an investment in the Company would be at risk. Past performance is not a guide to future performance and the information in this announcement or any documents relating to the Placing Programme cannot be relied on as a guide to future performance. Persons needing advice should contact a professional adviser.

 

END

 

 

MSCBXGDUISGBGRI